5 completed, 3 terminated, 1 recruiting, 1 withdrawn. 3 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
| Not applicable | 2 | Recruiting 1, Terminated 1 |
Follow Monteris Medical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REMASTer: REcurrent Brain Metastases After SRS Trial Radiation Therapy, Steroid Therapy, Laser Interstitial Thermal Therapy - Brain Metastases, Radiation Necrosis | Not applicable | Recruiting | Monteris Medical | 261 | 2022-05-10 | 2026-10-20 |
| PatiEnt Neuropsychological outcomeS After laseR Ablation Neuroblate System - Cognitive Change | Completed | Monteris Medical | 81 | 2021-09-29 | 2025-04-06 | |
| LITT and Pembrolizumab in Recurrent Brain Metastasis LITT + Pembrolizumab - Melanoma, Non-small Cell Lung Carcinoma (NSCLC) | Phase 1 | Terminated | University of Florida | 10 | 2020-01-10 | 2023-12-27 |
| LITT Palliative Treatment for Patients With Malignant Gliomas Palliative regimen consisting of LITT - Malignant Glioma of Brain, Glioblastoma | Withdrawn | Duke University | 2019-06-01 | 2019-02-27 | ||
| Feasibility Study on LITT for Newly Diagnosed Glioblastoma NeuroBlate System, Radiation therapy and temozolomide - Glioblastoma | Phase 1 | Terminated | Monteris Medical | 3 | 2017-08-15 | 2024-04-12 |
| Feasibility Study on LITT for Medical Refractory Epilepsy NeuroBlate System - Epilepsy | Not applicable | Terminated | Monteris Medical | 4 | 2017-04-21 | 2024-07-12 |
| Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System NeuroBlate System - Metastatic Brain Tumor, Primary Brain Tumor | Completed | Monteris Medical | 1153 | 2015-10-01 | 2025-04-24 | |
| Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry NeuroBlate® System Therapy - Primary Brain Tumor | Completed | Monteris Medical | 144 | 2015-02-01 | 2024-04-12 | |
| Laser Ablation After Stereotactic Radiosurgery Metastatic Brain Tumors, Progression | Completed | Monteris Medical | 44 | 2012-07-01 | 2024-04-15 | |
| Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors AutoLITT system - Brain Tumor, Brain Tumor, Recurrent | Phase 1 | Completed | Monteris Medical | 10 | 2008-08-01 | 2021-08-24 |
Brain Neoplasms (6) · Disease Progression (3) · Glioblastoma (3) · Epilepsy (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Esophageal Neoplasms (1) · Melanoma (1) · Movement Disorders (1) · Neoplasm Metastasis (1) · Recurrence (1) · Seizures (1)
Radiotherapy (2) · Temozolomide (1) · pembrolizumab (1)
United States (10)
Andrew Sloan, MD (1) · Andrew Sloan, MD, PhD (1) · Dennis Spencer, MD (1) · Eric Leuthardt, MD (1) · Gene Barnett, MD (1) · Manmeet Ahluwalia, MD (1) · Maryam Rahman, MD (1) · Patrick Landazuri, MD (1) · Peter Fecci, MD (1) · Peter S Fecci, MD, PhD (1) · Sujit Prabhu, MD (1) · Sujit Prabu, MD, PhD (1) · Veronica Chiang, MD (1)
PMID 23560574, PMID 29726782, PMID 31076762, PMID 32315434, PMID 33045664, PMID 42607280